Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01266161 · ClinicalTrials.gov registry record · Phase 3
Multiple Dose Dental Pain Study Of Ibuprofen Extended Release
A Phase 3 study of Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 106
- Enrollment target
- 2
- Study locations
NCT01266161 is a Phase 3 study of Pain that has completed, run by Pfizer. The registered enrollment target is 106 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01266161, a Phase 3 study of Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 106 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide analgesic efficacy superior to placebo over 12-hour dosing intervals.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ibuprofen 600 mg ER
Study Locations (2)
Texas
- Central Texas Oral Surgery Associates - Austin
- Premier Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2010-11-22 |
| Est. Completion | 2011-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01266161
The ClinicalTrials.gov registry entry for NCT01266161 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (65% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01266161 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01266161 about?
NCT01266161 is a clinical study titled "Multiple Dose Dental Pain Study Of Ibuprofen Extended Release". The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide analgesic efficacy superior to placebo over 12-hour dosing intervals.
What is the current status of trial NCT01266161?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 106 participants. The study started on 2010-11-22. Estimated completion is 2011-03-31.
What conditions does trial NCT01266161 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT01266161?
The interventions under investigation include: Placebo (DRUG), Ibuprofen 600 mg ER (DRUG).
Who is sponsoring clinical trial NCT01266161?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01266161 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.